CCG 203769 is a selective G protein signaling ( RGS4 ) inhibitor, which blocks the RGS4-Gα o protein-protein interaction in vitro with an IC 50 of 17 nM.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > RGS Protein
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.